We have shown that MYB drives proliferation and suppresses apoptosis and differentiation in estrogen receptor (ER)-positive breast cancer cells in response to estrogen [16,17], and that it is essential for mammary carcinogenesis in xenograft and transgenic models [18]. Here, MYB is linked to breast carcinoma.